Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 18, 1225-1231, November 1, 1958]
© 1958 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tannenbaum, A.
Right arrow Articles by Silverstone, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tannenbaum, A.
Right arrow Articles by Silverstone, H.

Urethan (Ethyl Carbamate) as a Multipotential Carcinogen*

Albert Tannenbaum and Herbert Silverstone{dagger}

( Department of Cancer Research, Medical Research Institute, Michael Reese Hospital,,{ddagger} Chicago 16, Ill.)

1. Long-term application of a solution of 20 per cent urethan in acetone was made to the skin of the interscapular area of (C57BL female x C3H male)F1, DBA, and C3H mice. This chronic treatment was continued for periods ranging up to 18 months and total amounts of urethan as high as 1800 mg/mouse.
2. Urethan did not evoke skin tumors at the site of application.
3. However, five separate and distinct lesions were induced or potentiated by the long-term application of urethan to the skin of the mice: pulmonary adenomas, mammary carcinomas, malignant mesenchymal tumors in the interscapular fat, cystadenomas of the lacrimal gland, and blood cysts in the liver.
4. Urethan is a multipotential carcinogen.

* This work was supported by research grants from the Damon Runyon Memorial Fund (DRG-250) and the U.S. Public Health Service (C-3787).

{dagger} Deceased May 31, 1956.

{ddagger} Supported, in part, by the Foundation for Cancer Research, Chicago, and its affiliates: Bertha Adlerblum Memorial Cancer League and Mildred Lasser Balter Cancer Memorial.

Received 6/30/58.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1958 by the American Association for Cancer Research.